Amgen Inc. said that Chief Financial Officer Jonathan M. Peacock is leaving to pursue other career opportunities, the Wall Street Journal reports. The biotech named Michael A. Kelly as acting CFO.
11150 Santa Monica Boulevard, Suite 350
Los Angeles, CA 90025
323-549-5225
© Los Angeles Business Journal